FENC vs NOK · rev $17.9M vs P/E 87, $78.04B cap
Fennec Pharmaceuticals Inc (FENC) versus Nokia Corp ADR (NOK) — a side-by-side from cached financials, not a winner call.
Fennec Pharmaceuticals Inc (FENC) is a biotechnology company listed on US.
Nokia Corp ADR (NOK) is a communication equipment company listed on NYSE.
Latest reported FENC revenue for 2026-06-30 was $17.9M. Net income was $2.0M. Revenue was up 18.3% from 2026-03-31 to 2026-06-30. FENC currently screens at market cap $302.2M.
NOK does not have a complete income-statement cache yet.
FENC currently screens at market cap $302.2M. NOK currently screens at market cap $78.04B and trailing P/E 87.4.
Not investment advice. Open the FENC and NOK stock pages for the full models.
Not investment advice.